V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20182155 | 20134601 | 1.79 | 64 | Palliative (P) | 2020-07-14 | 2020-07-14 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | ACTICCA-1 TRIAL | 101007419 |
| 20182177 | 20134602 | 1.82 | 72.6 | Adjuvant (A) | 2018-11-18 | 2019-01-02 | Alectinib | 02 | null | FOXTROT TRIAL | 100068210 |
| 20182397 | 20134605 | 1.51 | 59 | Palliative (P) | 2019-08-17 | 2019-08-17 | Letrozole + Palbociclib | null | Y | TEMOZOLOMIDE | 100065609 |
| 20182493 | 20134606 | 1.71 | 84.6 | Palliative (P) | 2016-10-14 | 2017-02-16 | Cape +Cetuximab +Oxalip (3 wk) Load | 02 | N | CISPLATIN + GEMCITABINE + RITUXIMAB | 100817564 |
| 20182777 | 20134607 | 1.54 | 57.5 | Neo-adjuvant (N) | 2022-02-03 | 2022-02-03 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | null | PHITT D CARBOPLATIN/DOXORUBICIN | 100892704 |
| 20182899 | 20134609 | 1.71 | 66 | null | 2019-10-11 | 2019-10-30 | CAPECITABINE + OXALIPLATIN + Trastuzumab | 02 | N | GEMCITABINE + RT | 101178269 |
| 20183014 | 20134610 | 1.72 | 105 | Palliative (P) | 2020-05-19 | 2020-06-08 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | N | CAPECITABINE + STREPTOZOCIN | 100735067 |
| 20183119 | 20134612 | 1.56 | 60.7 | Neo-adjuvant (N) | null | 2018-08-02 | IBRUTINIB | null | N | PALBOCICLIB | 101296146 |
| 20183306 | 20134613 | 1.55 | 65 | null | 2017-08-19 | 2017-08-19 | IPILIMUMAB + NIVOLUMAB | 02 | N | ECF | 100379481 |
| 20183410 | 20134614 | 1.54 | null | 03 | 2018-02-14 | 2018-02-15 | BCG Intravesical | null | N | AFATINIB | 100837195 |
| 20183463 | 20134615 | 1.56 | 56.4 | null | 2016-09-20 | 2016-10-05 | GemCarbo Days 1+8 | 02 | null | FLUOROURACIL + STREPTOZOCIN | 101746146 |
| 20183556 | 20134616 | 1.8 | 108 | Palliative (P) | 2019-07-20 | 2019-08-03 | DA 3+8 | N | null | ECARBOX | 100595571 |
| 20183636 | 20134617 | 1.53 | 65.1 | Palliative (P) | 2017-04-26 | 2017-05-02 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | BACILLUS CALMETTE-GUERIN | 101658752 |
| 20183764 | 20134618 | 1.55 | 66.75 | 03 | 2017-06-12 | 2018-04-01 | SCOPE 1 TRIAL | Y | N | MITOXANTRONE | 100851702 |
| 20183907 | 20134620 | 1.77 | 88 | Palliative (P) | null | 2019-12-19 | ABEMACICLIB + FULVESTRANT | 01 | N | CYCLOPHOSPHAMIDE + LENALIDOMIDE | 101672692 |
| 20183944 | 20134621 | 0 | 0 | null | 2021-12-17 | 2022-02-01 | ECF | 02 | null | ECF | 101521617 |
| 20184308 | 20134622 | null | null | Palliative (P) | 2021-10-12 | 2021-11-13 | CAPECITABINE + IRINOTECAN + Panitumumab | 02 | N | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 100669532 |
| 20184496 | 20134623 | 0 | 64.4 | Palliative (P) | 2017-06-03 | 2017-06-07 | Carboplatin + Pemetrexed | 02 | N | ATEZOLIZUMAB | 100023712 |
| 20184560 | 20134624 | 1.86 | 48 | Curative (C) | 2019-04-09 | 2019-04-20 | SCOPE 2 TRIAL | 01 | N | OXALIPLATIN + MDG + PANITUMUMAB | 101540921 |
| 20184701 | 20134625 | 1.77 | 90.6 | null | 2019-12-09 | 2019-12-09 | null | 02 | null | CISPLATIN + RALTITREXED | 101683991 |
| 20184708 | 20134626 | 1.75 | 98.25 | Palliative (P) | 2019-04-29 | 2019-07-09 | Temozolomide + RT | 02 | null | SCOPE 1 TRIAL | 100844082 |
| 20184820 | 20134627 | 1.89 | 66.4 | null | 2016-05-08 | 2016-05-22 | Irinotecan + Raltitrexed | 02 | N | BORTEZOMIB + DARATUMUMAB | 100129984 |
| 20184976 | 20134628 | 0 | 74.6 | Palliative (P) | 2018-04-01 | 2018-04-29 | ECF | 02 | N | GEMCITABINE + PACLITAXEL | 100602943 |
| 20185051 | 20134629 | 1.72 | 68.9 | null | 2017-11-25 | 2017-11-25 | FCarboSt | 02 | null | CYCLOPHOSPHAMIDE + FLUDARABINE | 101307877 |
| 20185506 | 20134630 | 0.7 | 82 | Palliative (P) | 2018-03-15 | 2018-03-16 | FEC | N | null | LIPOSOMAL DOXORUBICIN | 101528267 |
| 20185523 | 20134631 | 1.7 | 66 | Curative (C) | 2017-04-03 | 2017-05-01 | EEF or EOF | 99 | N | FLUOROURACIL + PANITUMUMAB | 101382889 |
| 20185668 | 20134632 | 0 | 96.9 | null | 2019-06-26 | 2019-07-02 | CETUXIMAB + RT | 02 | N | PACLITAXEL + RAMUCIRUMAB | 100764490 |
| 20185965 | 20134633 | null | null | Palliative (P) | 2020-06-06 | 2020-06-20 | Azacitidine | N | N | BEVACIZUMAB + CAPECITABINE + OXALIPLATIN | 101692704 |
| 20186177 | 20134634 | 1.8 | 65.8 | null | 2018-12-30 | 2018-12-30 | DA 3+8 | 02 | null | CAPECITABINE + IRINOTECAN + PANITUMUMAB | 100061844 |
| 20186215 | 20134635 | 1.57 | 84.2 | Curative (C) | 2018-06-09 | 2018-06-18 | Gemcitabine + Oxaliplatin | 02 | N | BENDAMUSTINE + RITUXIMAB | 100845002 |
| 20186229 | 20134636 | 1.57 | 72.5 | Palliative (P) | 2021-09-24 | 2021-09-24 | Carboplatin + Cetux + FU (Cycle 1) | 02 | null | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100923727 |
| 20186389 | 20134637 | 1.65 | 83.1 | Curative (C) | 2019-09-05 | 2019-09-05 | Cetuximab + FLUOROURACIL | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101404371 |
| 20187070 | 20134639 | 1.56 | 0 | Palliative (P) | 2017-06-27 | 2017-07-04 | PHITT Trial | 02 | null | CISPLATIN + FLUOROURACIL + TRASTUZUMAB | 101775934 |
| 20187184 | 20134640 | null | null | Curative (C) | 2019-02-10 | 2019-09-17 | TEMOZOLOMIDE | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPATIN | 101518294 |
| 20187251 | 20134641 | 1.84 | 60.5 | Adjuvant (A) | 2018-05-23 | 2018-05-23 | Brentuximab | 02 | N | CYCLOPHOSPHAMIDE + RITUXIMAB | 101844547 |
| 20187474 | 20134642 | 1.7 | 77.7 | 03 | 2018-01-31 | 2018-02-14 | Rituximab (INTRAVENOUS Maintenance) | 99 | N | PHITT D2 CARBOPLATIN / ETOPOSIDE | 100259446 |
| 20188507 | 20134645 | 1.54 | null | Curative (C) | 2018-08-27 | 2018-11-23 | CISPLATIN + FLUOROURACIL + Trastuzumab | 2 | N | BEVACIZUMAB + FLUOROURACIL + IRINOTECAN | 100759450 |
| 20188987 | 20134647 | 1.72 | 51.7 | Palliative (P) | 2020-08-11 | 2020-08-20 | Azacitidine | N | N | BEVACIZUMAB + IRINOTECAN + MdG | 101684297 |
| 20189120 | 20134648 | 1.65 | null | 03 | 2017-01-26 | 2017-01-26 | Binimetinib + Encorafenib | 2 | N | FLUOROURACIL + RT | 100307706 |
| 20189383 | 20134649 | 1.66 | 11 | Palliative (P) | null | 2022-01-19 | Palbociclib | null | null | ECARBOX | 100701518 |
| 20189803 | 20134650 | 1.69 | 100.6 | null | 2017-11-02 | 2017-11-02 | ECarboF | 02 | null | TEMOZOLOMIDE | 100286221 |
| 20189888 | 20134652 | 1.83 | 116 | null | 2016-08-02 | 2017-11-25 | CISPLATIN + FLUOROURACIL + RT | 02 | Y | VINORELBINE | 100851622 |
| 20189892 | 20134653 | 1.51 | 92.8 | 03 | 2016-05-23 | 2018-05-09 | Alemtuzumab | Y | N | BORTEZOMIB + DARATUMUMAB | 100827881 |
| 20189948 | 20134654 | 1.55 | 74 | Curative (C) | 2019-01-09 | 2019-01-09 | DOCETAXEL + PERTUZUMAB + TRASTUZUMAB | 02 | null | PAZOPANIB | 100494024 |
| 20190046 | 20134655 | 1.75 | 83.8 | Palliative (P) | 2016-10-24 | 2016-10-24 | ECF | 02 | N | SCOPE2 TRIAL | 101597597 |
| 20190080 | 20134656 | 1.71 | 0 | Palliative (P) | 2020-04-03 | 2020-04-03 | null | 02 | N | POMALIDOMIDE | 101597281 |
| 20190292 | 20134657 | 1.69 | 88.4 | null | 2018-05-08 | 2018-05-30 | null | null | null | GEMCITABINE + RT | 101266166 |
| 20190312 | 20134658 | 1.82 | 77.9 | null | 2017-11-28 | 2018-08-28 | ECF | 02 | null | AFATINIB | 100306812 |
| 20190786 | 20134660 | 1.63 | 59.4 | Curative (C) | 2019-01-03 | 2019-01-10 | BCG Intravesical | 02 | N | CYTARABINE + DAUNORUBICIN | 101626160 |
| 20190951 | 20134662 | 1.81 | 70.6 | 03 | 2018-03-03 | 2018-03-03 | Erlotinib | 02 | null | FLUOROURACIL + RT | 101577790 |